PK
Paul Kelly
Angel InvestorActivePaul has over 25 years experience in developing and commercialising biomedical innovations in United States, Europe, United Kingdom and Aust...
Sydney, AustraliaFounded 2016
24
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Paul Kelly.
Investment Thesis & Strategy
Paul Kelly, as an angel investor, likely invests in early-stage companies across various industries, leveraging his extensive experience in biomedical innovation to identify promising ventures. He may focus on companies with strong potential for commercialization in the US, Europe, UK, and Australia.
Investment Activity
Deals per year over the last 6 years
6
20161
20171
20181
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 24 companies
M
Murdoch Childrens Research Institute (MCRI)
Healthcare · Seed, 0
P
Paragen Bio
Biotech · Seed, 2021
M
Madorra
Healthcare · Seed, 2020
Z
Zoomo
Transportation · Series A, 2019
K
Kira Biotech
Biotech · Seed, 2018
A
AdGent Digital
Other · Seed, 2017
P
Prota Therapeutics
Biotech · Seed, 2016
S
Shippit
Logistics · Series A, 2016
8
8i
Media/Content · Seed, 2016
H
Hometime
Real Estate · Seed, 2016
B
BiVACOR
Biotech · Seed, 2016
B
Blade Therapeutics
Biotech · Series C+, 2016
Frequently Asked Questions
Paul Kelly focuses on Pre-seed, Seed stage investments.